241 related articles for article (PubMed ID: 35527085)
1. Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives.
Horowitz T; Grimaldi S; Azulay JP; Guedj E
Rev Neurol (Paris); 2022 May; 178(5):484-489. PubMed ID: 35527085
[TBL] [Abstract][Full Text] [Related]
2. Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast-Developing Field.
Verger A; Grimaldi S; Ribeiro MJ; Frismand S; Guedj E
Ann Neurol; 2021 Nov; 90(5):711-719. PubMed ID: 34338333
[TBL] [Abstract][Full Text] [Related]
3. PET Molecular Imaging in Atypical Parkinsonism.
Xu Z; Arbizu J; Pavese N
Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
[TBL] [Abstract][Full Text] [Related]
4. Update on SPECT and PET in parkinsonism - part 1: imaging for differential diagnosis.
Meyer PT; Hellwig S
Curr Opin Neurol; 2014 Aug; 27(4):390-7. PubMed ID: 24950013
[TBL] [Abstract][Full Text] [Related]
5. [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].
Meyer PT; Amtage F; Hellwig S
Nervenarzt; 2014 Jun; 85(6):680-9. PubMed ID: 24821290
[TBL] [Abstract][Full Text] [Related]
6. SPECT Molecular Imaging in Atypical Parkinsonism.
Brumberg J; Isaias IU
Int Rev Neurobiol; 2018; 142():37-65. PubMed ID: 30409259
[TBL] [Abstract][Full Text] [Related]
7. [Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].
Arbizu J; Luquin MR; Abella J; de la Fuente-Fernández R; Fernandez-Torrón R; García-Solís D; Garrastachu P; Jiménez-Hoyuela JM; Llaneza M; Lomeña F; Lorenzo-Bosquet C; Martí MJ; Martinez-Castrillo JC; Mir P; Mitjavila M; Ruiz-Martínez J; Vela L
Rev Esp Med Nucl Imagen Mol; 2014; 33(4):215-26. PubMed ID: 24731551
[TBL] [Abstract][Full Text] [Related]
8. What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.
Thobois S; Prange S; Scheiber C; Broussolle E
Parkinsonism Relat Disord; 2019 Feb; 59():93-100. PubMed ID: 30181086
[TBL] [Abstract][Full Text] [Related]
9. The role of molecular imaging in assessing degenerative parkinsonism - an updated review.
Nicastro N; Garibotto V; Burkhard PR
Swiss Med Wkly; 2018; 148():w14621. PubMed ID: 29698545
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
11. [Functional neuroimaging with SPECT in Parkinson's disease and Parkinsonisms].
Lorenzo-Bosquet C; Hernández-Vara J; Castell-Conesa J; Miquel-Rodríguez F
Rev Neurol; 2008 Apr 1-15; 46(7):430-5. PubMed ID: 18389463
[TBL] [Abstract][Full Text] [Related]
12. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Utility of [11C]DTBZ Positron Emission Tomography In Clinically Uncertain Parkinsonism: Experience of a Single Tertiary Center.
Pérez-Lohman C; Kerik NE; Díaz-Meneses IE; Cervantes-Arriaga A; Rodríguez-Violante M
Rev Invest Clin; 2018; 70(6):285-290. PubMed ID: 30532098
[TBL] [Abstract][Full Text] [Related]
15. Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.
Buchert R; Buhmann C; Apostolova I; Meyer PT; Gallinat J
Dtsch Arztebl Int; 2019 Nov; 116(44):747-754. PubMed ID: 31774054
[TBL] [Abstract][Full Text] [Related]
16. Imaging in Movement Disorders.
Maiti B; Perlmutter JS
Continuum (Minneap Minn); 2023 Feb; 29(1):194-218. PubMed ID: 36795878
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
18. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
19. International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism.
Tian M; Zuo C; Cahid Civelek A; Carrio I; Watanabe Y; Kang KW; Murakami K; Prior JO; Zhong Y; Dou X; Yu C; Jin C; Zhou R; Liu F; Li X; Lu J; Zhang H; Wang J;
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):434-442. PubMed ID: 37789188
[TBL] [Abstract][Full Text] [Related]
20. The challenging quest of neuroimaging: From clinical to molecular-based subtyping of Parkinson disease and atypical parkinsonisms.
Sasikumar S; Strafella AP
Handb Clin Neurol; 2023; 192():231-258. PubMed ID: 36796945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
